SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Siro could be a booster for Biocon

08 Mar 2010 Evaluate

Biocon may gain from a possible alliance with clinical research organisation Siro Clinpharm. Biocon will not only get access to Siro’s huge client base, but the deal will also help its subsidiary Syngene get attractive valuations. Siro offers services ranging from data management, pharmacovigilance, medical writing, bio-statistics, etc. which can bolster Biocon’s clinical trials expertise. Biocon will be able to use Siro’s client base to get more clinical trials work and thus get more projects.

Siro is a strategic fit for Biocon subsidiaries Clinigene and Syngene. Biocon is looking at listing Syngene and if Siro gets acquired and merged with Syngene, the valuations will be better. Syngene does contract research for pharmaceutical companies, while Clinigene manages clinical trials for drug companies.

crackcrack

Biocon Share Price

383.05 2.30 (0.60%)
07-May-2026 11:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.20
Dr. Reddys Lab 1307.10
Cipla 1368.95
Zydus Lifesciences 941.70
Lupin 2470.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×